Notice of Correction of PA-18-871, "BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 Clinical Trial Not Allowed) "

Notice Number: NOT-MH-18-051

Key Dates
Release Date: September 04, 2018

Related Announcements
PA-18-871

Issued by
National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice to clarify the Application Types allowed in PA-18-871, BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 Clinical Trial Not Allowed).

Currently reads

Section II. Award Information 

Application Types Allowed

New (Phase I)
Renewal (Phase II* Direct Phase II not allowed)
Resubmission (all phases)
Revision

The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.

Modified to read 

Section II. Award Information   

Application Types Allowed 

New (Phase I, Fast Track)
Renewal (Phase II* Direct Phase II not allowed)
Resubmission (all phases)
Revision

The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.

All other aspects of this FOA remain unchanged. 

Inquiries

Please direct all inquiries to:

Margaret Grabb, PhD
National Institute of Mental Health (NIMH)
Telephone:  301-443-3563
Email:  mgrabb@mail.nih.gov